Guardant Health logo

Associate Business Development Director - Oncology BioPharma

Guardant Health

Any City, MDHybridPosted 32 days ago$162,265 - $236,250/year
Full TimeSenior LevelCommercial & Pharma SalesDiagnostics
Original posting ↗

Summary

The Associate Business Development Director - Oncology BioPharma will play a key leadership role within Guardant Health's BioPharma Business Development team, responsible for expanding and managing strategic biopharma partnerships across the oncology portfolio. This role supports strategy creation and drives larger initiatives spanning multiple internal and external stakeholder groups, with accountability for developing new accounts, growing existing partnerships, advancing commercial opportunities, and delivering an outstanding partner experience.

Job description

Essential Duties and Responsibilities

  • Meet new prospects and existing customers, identify, qualify, and pursue new business opportunities with biopharma, to support revenue growth, translational medicine, companion diagnostics, screening and oncology market access, product visibility, and long-term strategic objectives.
  • Develop business cases to support application expansion and execute account and partnership strategies that expand Guardant Health's biopharma oncology business, moving opportunities from transactional engagements toward broader, integrated partnerships across Guardant's suite of capabilities.
  • Lead the management of existing partner relationships and commercial opportunities, including aligning win-win opportunities between Guardant's capabilities and the client's portfolio, meeting preparation and execution, proposal development, pricing discussions, contract negotiations, and closing of agreements that align with business goals and strengthen long-term customer relationships.
  • Guide and educate external partners, including biomarker researchers, translational medicine scientists, clinical development leaders, and global commercial teams, on Guardant's oncology portfolio, data capabilities, clinical trial services, and companion diagnostic opportunities.
  • Lead cross-functional collaboration with Research Operations, Alliance Management, Bioinformatics, DAP, Quality, Global Scientific Affairs, Clinical Trial Operations, Product, Legal, Finance, Marketing, Regulatory, Translational Sciences R&D, and commercial teams to address customer needs, resolve issues, and deliver a high-quality partner experience.
  • Conduct market and customer analysis to identify oncology market dynamics, competitive trends, customer needs, pricing considerations, and partnership opportunities that inform account planning and commercial strategy.
  • Develop business cases, sales forecasts, account plans, and executive-ready updates that provide insight into pipeline health, revenue opportunities, customer trends, competitive intelligence, and strategic tradeoffs.
  • Partner with BioPharma leadership to communicate partner needs and priorities, support strategic initiatives, and influence internal decisions needed to advance high-value business development opportunities.
  • Build and maintain relationships with biopharma decision-makers, and industry stakeholders to strengthen Guardant's visibility, credibility, and adoption across oncology partnerships.
  • Represent Guardant Health at industry conferences, customer meetings, scientific forums, and networking events to promote the oncology portfolio and identify new partnership opportunities.
  • Follow business development processes, tools, training materials, and best practices that improve team effectiveness and enable consistent execution across accounts.

Qualifications

  • Typically requires a bachelor's degree in Life Sciences, Business Administration, or related field with 8-10+ years of relevant experience; MBA or advanced degree preferred.
  • 8+ years of experience in business development, sales, consulting, diagnostics, biopharma, CROs, oncology, precision medicine, or related life sciences.
  • Experience developing and closing fee for services, companion diagnostics, commercial agreements, both transaction and complex, including contract negotiation, account growth, and partner management.
  • Strong understanding of oncology, biomarker development, companion diagnostics, clinical trial services, sequencing technologies, precision medicine, and clinical diagnostics market dynamics, including regulatory, reimbursement, and market access considerations.
  • Demonstrated resourcefulness and ability to operate with broad latitude, prioritize complex opportunities, influence cross-functional teams, resolve tradeoffs, and drive decisions in ambiguous or fast-moving situations.
  • Strong analytical, commercial, communication, presentation, and relationship-building skills, including market analysis, forecasting, business case development, pipeline management, executive reporting, and translating complex scientific and business concepts for senior stakeholders.
  • Track record in epigenomics or application development is a plus.
  • Independent, proactive self-starter who can regularly hunt while managing multiple opportunities, balance emerging and ongoing relationships, deliver commitments on time, build scalable processes, and support broader team success.
  • Remote, hybrid, or office-based per business needs and Guardant Health policy; up to 75% travel may be required.

AI & Digital Fluency

Demonstrate curiosity, sound judgment, and the ability to critically evaluate and responsibly leverage AI-enabled tools in accordance with company policies, ethical standards, and regulatory requirements to improve the efficiency, effectiveness, and quality of work.

Requirements

  • Bachelor's degree in Life Sciences, Business Administration, or related field
  • 8-10+ years of relevant experience
  • 8+ years of experience in business development, sales, consulting, diagnostics, biopharma, CROs, oncology, precision medicine, or related life sciences
  • Experience developing and closing fee for services, companion diagnostics, commercial agreements, including contract negotiation, account growth, and partner management
  • Strong understanding of oncology, biomarker development, companion diagnostics, clinical trial services, sequencing technologies, precision medicine, and clinical diagnostics market dynamics
  • Knowledge of regulatory, reimbursement, and market access considerations
  • Demonstrated resourcefulness and ability to operate with broad latitude, prioritize complex opportunities, influence cross-functional teams, resolve tradeoffs, and drive decisions in ambiguous or fast-moving situations
  • Strong analytical, commercial, communication, presentation, and relationship-building skills
  • Experience with market analysis, forecasting, business case development, pipeline management, executive reporting, and translating complex scientific and business concepts for senior stakeholders
  • Independent, proactive self-starter who can regularly hunt while managing multiple opportunities, balance emerging and ongoing relationships, deliver commitments on time, build scalable processes, and support broader team success
  • Ability to travel up to 75%

Benefits

  • Medical, Dental & Vision
  • 401(k) Matching
  • Unlimited PTO
  • Hybrid Work Model
  • Flexible Work Arrangements

Company overview

Guardant Health, Inc. is a leading precision oncology company headquartered in Palo Alto, California, focused on transforming cancer care through advanced blood and tissue testing technologies. Founded in 2012 by Helmy Eltoukhy and AmirAli Talasaz, who serve as co-CEOs, the company specializes in liquid biopsy tests that detect cancer from circulating tumor DNA in blood samples. Guardant Health's flagship product, Guardant360, was the first comprehensive liquid biopsy test approved by the FDA for tumor mutation profiling and companion diagnostics in non-small cell lung cancer. The company has expanded its portfolio to include Guardant Reveal for residual disease monitoring, Guardant360 TissueNext tissue testing, and Shield, the first FDA-approved blood test for colorectal cancer screening. Guardant Health operates globally with approximately 1,999 employees and generates revenue from precision oncology testing services for clinical and biopharmaceutical customers, as well as development services and technology licensing. The company's innovative approach enables earlier cancer detection, treatment selection, and monitoring, helping to improve patient outcomes across all stages of cancer care.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.